ISBER Position Statements
June 27, 2022 Comments on NIH Draft Supplemental Information to the NIH Policy for Data Management and Sharing: Protecting Privacy When Sharing Human Research Participant Data NOT-OD-22-131
Submitted by the ISBER Science Policy Committee 
February 25, 2022 Comments on Request for Information on the NIH Genomic Data Sharing Policy, NOT-OD-22-029
Submitted by the ISBER Science Policy Committee 
September 27, 2021 Comments on NIH’s Request for Information: Developing Consent Language for Future Use of Data and Biospecimens, NOT-OD-21-131
Submitted by the ISBER Science Policy Committee 
 June 10, 2020 Responsible Data Sharing to Respond to the COVID-19 Pandemic: Ethical and Legal Considerations (v 2.0): The Perspective of the Regulatory and Ethics Work Stream of the Global Alliance for Genomics and Health
Submitted by the ISBER Science Policy Committee 
 April 29, 2020 Comments on Application of GDPR to Biomedical Research
Submitted by the ISBER Science Policy Committee 
 January 7, 2020 Comments on the Draft NIH Policy for Data Management and Sharing
Submitted by the ISBER Science Policy Committee 
 August 1, 2019 Comments on GA4GH Data and Security Policy
Submitted by the ISBER Science Policy Committee 
 February 11, 2019 Docket No. FDA-2018—N-2727, "Institutional Review Board Waiver or Alteration of Informed Consent for Minimal Risk Clinical Investigations" (83 Federal Register 57378)
Submitted by the ISBER Science Policy Committee 
 January 3, 2018 Comments relating to the Proposed Changes to TCPS 2 (2014) Guidance for Research involving Human Cells and Cell Lines
Submitted by the ISBER Science Policy Committee 
 February 29, 2016 Comments relating to the CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects
Submitted by the ISBER Science Policy Committee
November 18, 2015 Comments on Notice of Proposed Rulemaking for Revisions to the Common Rule
Submitted by the ISBER Science Policy Committee
November 16, 2015 Missed Opportunities and Lost Lives: Consequences of Some Proposed Changes to Regulations on Research with Human Tissues
Reprinted by permission from the American Association for Cancer Research: Grizzle WE.
Missed opportunities and lost lives: consequences of some proposed changes to regulations on research with human tissues. Clin Can Res. 2015 19. [Epub ahead of print]. doi:10.1158/1078-0432.CCR-15-2513.
June 11, 2015 Comments on the World Medical Association (WMA) Declaration of Ethical Considerations Regarding Health Databases and Biobanks
Submitted by the ISBER Science Policy Committee
August 12, 2014 Comments on the Working Document on Research on Biological Materials of Human Origin to the Committee on Bioethics of the Council of Europe
Submitted by the ISBER Science Policy Committee
July 1, 2014 Comments on the International Code of Conduct for Genomic and Health-Related Data Sharing
Submitted by the ISBER Science Policy Committee
November 20, 2013 Response to the Request for Public Comments on the Draft Genomic Data Sharing (GDS) Policy
Submitted by the ISBER Science Policy Committee
July 8, 2013 Response to the U.S. Presidential Commission for the Study of Bioethical Issues Request for Comments on Issues Related to Incidental Findings
Submitted by the ISBER Science Policy Committee
March 4, 2013 Response to the European General Data Protection Regulation Proposal
as provided by the European Parliament and the Council of the European Union
, (Brussels, 4 December 2012)
Submitted by the ISBER Science Policy Committee
January 12, 2012 Australian government National Health and Medical Research Council (NHMRC) proposed revisions to Chapter 3.4: human tissue samples and Chapter 3.6: Human stem cells of the National Statement on Ethical Conduct in Human Research
Submitted by the ISBER Science Policy Committee
October 26, 2011 Federal Government of U.S.A. Health and Human Services Department (May 31, 2011) proposed changes to Common Rule
Submitted by the ISBER Science Policy Committee